145 related articles for article (PubMed ID: 8608528)
21. Prognostic significance of MRI findings in patients with myxoid-round cell liposarcoma.
Tateishi U; Hasegawa T; Beppu Y; Kawai A; Satake M; Moriyama N
AJR Am J Roentgenol; 2004 Mar; 182(3):725-31. PubMed ID: 14975976
[TBL] [Abstract][Full Text] [Related]
22. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information.
Fetsch JF; Laskin WB; Hallman JR; Lupton GP; Miettinen M
Am J Surg Pathol; 2007 Jul; 31(7):1103-14. PubMed ID: 17592278
[TBL] [Abstract][Full Text] [Related]
23. Liposarcoma of the extremities: a review of the cases seen and managed in a major tertiary hospital in Singapore.
Ng YC; Tan MH
Singapore Med J; 2009 Sep; 50(9):857-61. PubMed ID: 19787170
[TBL] [Abstract][Full Text] [Related]
24. Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases.
Moreau LC; Turcotte R; Ferguson P; Wunder J; Clarkson P; Masri B; Isler M; Dion N; Werier J; Ghert M; Deheshi B;
Ann Surg Oncol; 2012 Apr; 19(4):1081-8. PubMed ID: 22052112
[TBL] [Abstract][Full Text] [Related]
25. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
26. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
27. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome.
Reith JD; Goldblum JR; Lyles RH; Weiss SW
Mod Pathol; 2000 May; 13(5):577-85. PubMed ID: 10824931
[TBL] [Abstract][Full Text] [Related]
28. Retroperitoneal liposarcoma: MR characteristics and pathological correlative analysis.
Song T; Shen J; Liang BL; Mai WW; Li Y; Guo HC
Abdom Imaging; 2007; 32(5):668-74. PubMed ID: 17387533
[TBL] [Abstract][Full Text] [Related]
29. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
Cheng H; Dodge J; Mehl E; Liu S; Poulin N; van de Rijn M; Nielsen TO
Hum Pathol; 2009 Sep; 40(9):1244-51. PubMed ID: 19368956
[TBL] [Abstract][Full Text] [Related]
30. p27(kip1) protein expression correlates with survival in myxoid and round-cell liposarcoma.
Oliveira AM; Nascimento AG; Okuno SH; Lloyd RV
J Clin Oncol; 2000 Aug; 18(15):2888-93. PubMed ID: 10920137
[TBL] [Abstract][Full Text] [Related]
31. Liposarcoma. A clinicopathologic subtyping of 52 cases.
Hashimoto H; Enjoji M
Acta Pathol Jpn; 1982 Nov; 32(6):933-48. PubMed ID: 6297235
[TBL] [Abstract][Full Text] [Related]
32. Primary subcutaneous myxoid liposarcoma: a clinicopathologic review of three cases with molecular confirmation and discussion of the differential diagnosis.
Buehler D; Marburger TB; Billings SD
J Cutan Pathol; 2014 Dec; 41(12):907-15. PubMed ID: 25376660
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up.
Lemeur M; Mattei JC; Souteyrand P; Chagnaud C; Curvale G; Rochwerger A
Orthop Traumatol Surg Res; 2015 Feb; 101(1):103-7. PubMed ID: 25583234
[TBL] [Abstract][Full Text] [Related]
34. Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.
Hoffman A; Ghadimi MP; Demicco EG; Creighton CJ; Torres K; Colombo C; Peng T; Lusby K; Ingram D; Hornick JL; Wang WL; Ravi V; Lazar AJ; Lev D; Pollock RE
Cancer; 2013 May; 119(10):1868-77. PubMed ID: 23401071
[TBL] [Abstract][Full Text] [Related]
35. The role of histology, grading, location of tumour and ploidy in evaluation of outcome in patients with liposarcoma.
Harazin-Lechowska A; Ambroziak-Lackowska B; Ryś J; Kruczak A; Gruchała A; Jaszcz-Gruchała A; Dańda D; Przewoźnik M; Halaszka K
Pol J Pathol; 2017; 68(4):343-351. PubMed ID: 29517205
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.
Nishida Y; Tsukushi S; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2010 Nov; 468(11):3041-6. PubMed ID: 20499293
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow up of pure myxoid liposarcomas with special reference to local recurrence and progression to round cell lesions.
Fukuda T; Oshiro Y; Yamamoto I; Tsuneyoshi M
Pathol Int; 1999 Aug; 49(8):710-5. PubMed ID: 10504538
[TBL] [Abstract][Full Text] [Related]
38. Myxoid/round cell conjunctival liposarcoma. A case report.
Giuri S; Raica M; Munteanu M
Rom J Morphol Embryol; 2013; 54(3):655-8. PubMed ID: 24068420
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years.
Knebel C; Lenze U; Pohlig F; Lenze F; Harrasser N; Suren C; Breitenbach J; Rechl H; von Eisenhart-Rothe R; Mühlhofer HML
BMC Cancer; 2017 Jun; 17(1):410. PubMed ID: 28606068
[TBL] [Abstract][Full Text] [Related]
40. Is multimodality therapy necessary for the management of pure myxoid liposarcomas? A multi-institutional series of pure myxoid liposarcomas of the extremities and torso.
Baxter KJ; Govsyeyev N; Namm JP; Gonzalez RJ; Roggin KK; Cardona K
J Surg Oncol; 2015 Feb; 111(2):146-51. PubMed ID: 25213588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
